Oncology

FDA is evaluating risks to patients.

From breast cancer to prostate cancer, the state of oncology care and how it will evolve.

FDA approved yet another indication for pembrolizumab (Keytruda) to treat patients with recurrent, locally advanced or metastatic, squamous cell carcinoma of the esophagus (ESCC).

Customized survivorship plans specific to the cancer the patient endured and the treatment they received are essential.

Oncologists are under intense pressure to come up with cost savings-and many are turning to value-based care structures.

Top oncology experts share how they deliver these therapies to patients in need.

A record number of new oncology treatments launched in the US last year and spending on cancer drugs soared. Here are the top 6 cancer drug trends revealed in the report.

A new NIH report on cancer in people aged 20 to 49 shows that while rates are declining, women and minorities still face significant rates.

Oncologists recognize the potential of artificial intelligence (AI) in improving the quality of care and patient outcomes according to new research.

The 2018 oncology drug market had a record number of new treatments and continued a trend of growth.

Biosimilar drugs are poised to transform the cancer drug market-so why is uptake so slow?

Managed Healthcare Executive asked top experts their predictions for the top game-changing therapies. Here’s what they said.

Jim Barlow of Geneos Therapeutics explains the role of value networks and strategies to increase cell therapy access.

FDA approves cabozantinib to treat patients with hepatocellular carcinoma, a community in need of new therapeutic options.

How Horizon BCBSNJ’s Episodes of Care program engages physicians in certain specialties in the value-based continuum.

IO therapies hold great promise, but often come with high price tags. How do payers feel about these medications?

The biggest drug categories and medications set for approval this year.

 A new non-small cell lung cancer (NSCLC) treatment is available to healthcare providers immediately.  

Walgreens' new integrated support program aims to help patients with cancer manage the side effects of undergoing treatment. Here’s five things to know about it.

New research from Cardinal Health Specialty Solutions has surprising findings about oncologists from meeting MACRA requirements to burnout.

Here are the top 2 novel cancer drugs cleared by the agency.

As immunotherapy breaks through in cancer therapy, here are five things to know about this promising treatment.

How Froedtert Hospital achieves success with a 24/7/365 cancer clinic.

Dealing with cancer is challenging enough for patients and providers. But even when their different perspectives are factored in, that’s not the whole story.

Cancer medication spending is unsustainable, but significant savings can be achieved just by reducing waste. Here’s how.

Experts predict what oncology care will look like a decade from now.

A Wamberg Genomic Advisors’ Cancer Survey has revealing findings from people dealing directly with cancer.

As lymphoma treatments become less cookie-cutter and more custom, the Leukemia & Lymphoma Society Chief Medical Officer Gwen Nichols, MD, shares how healthcare executives need to alter their approach to managing therapy regimens to increase cure rates and survivorship.

The ability of an oncology practice to succeed in the OCM varies depending on this key factor, according to Avalere research.

New cancer drugs continue to offer patients hope. Here are eight of them.